[HTML][HTML] Cellular mechanisms of circulating tumor cells during breast cancer metastasis

HA Park, SR Brown, Y Kim - International journal of molecular sciences, 2020 - mdpi.com
Circulating tumor cells (CTCs) are cancer cells that detach from the primary site and travel in
the blood stream. A higher number of CTCs increases the risk of breast cancer metastasis …

Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells

A Pavlopoulou, Y Oktay, K Vougas, M Louka… - Cancer letters, 2016 - Elsevier
Breast cancer cells are suggested to be organized in a hierarchical manner with a
subpopulation of stem cells, termed as breast cancer stem cells (BCSCs), which contribute …

Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2

Y Zhou, N Yamada, T Tanaka, T Hori… - Nature …, 2015 - nature.com
Crosstalk between inflammatory signalling pathways and receptor tyrosine kinases has
been revealed as an indicator of cancer malignant progression. In the present study, we …

YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer

D Jiang, T Qiu, J Peng, S Li, Tala, W Ren… - Cell Death & …, 2022 - nature.com
Y-box binding protein 1 (YB-1) is a well-known oncogene highly expressed in various
cancers, including basal-like breast cancer (BLBC). Beyond its role as a transcription factor …

Patient-level proteomic network prediction by explainable artificial intelligence

P Keyl, M Bockmayr, D Heim, G Dernbach… - NPJ Precision …, 2022 - nature.com
Understanding the pathological properties of dysregulated protein networks in individual
patients' tumors is the basis for precision therapy. Functional experiments are commonly …

Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm

E Martinez-Ledesma, RGW Verhaak, V Treviño - Scientific reports, 2015 - nature.com
Cancer types are commonly classified by histopathology and more recently through
molecular characteristics such as gene expression, mutations, copy number variations and …

RSK inhibitors as potential anticancer agents: discovery, optimization, and challenges

Y Sun, L Tang, C Wu, J Wang, C Wang - European Journal of Medicinal …, 2023 - Elsevier
Ribosomal S6 kinase (RSK) family is a group of serine/threonine kinases, including four
isoforms (RSK1/2/3/4). As a downstream effector of the Ras-mitogen-activated protein …

Personalizing the treatment of pediatric medulloblastoma: polo-like kinase 1 as a molecular target in high-risk children

J Triscott, C Lee, C Foster, B Manoranjan… - Cancer …, 2013 - aacrjournals.org
Medulloblastoma is the most common malignant brain tumor in children. This disease is
heterogeneous and is composed of four subtypes of medulloblastoma [WNT, Sonic …

miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1

M Xu, H **, CX Xu, B Sun, ZG Song, WZ Bi, Y Wang - Molecular therapy, 2015 - cell.com
Lung metastasis and relapse in osteosarcoma (OS) patients indicate poor prognosis. Here,
we identified significantly decreased expression of miR-382 in highly metastatic OS cell …

ERα binding by transcription factors NFIB and YBX1 enables FGFR2 signaling to modulate estrogen responsiveness in breast cancer

TM Campbell, MAA Castro, KG de Oliveira… - Cancer …, 2018 - aacrjournals.org
Two opposing clusters of transcription factors (TF) have been associated with the differential
risks of estrogen receptor positive or negative breast cancers, but the mechanisms …